Cannabis Investing Lobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands
Pharmaceutical Investing Health Canada Approves KEYTRUDA® as First-line Treatment for Adults with Metastatic Microsatellite Instability-High or Mismatch Repair Deficient Colorectal Cancer
Medical Device Investing Solta Medical Announces the U.S. Launch of The Clear + Brilliant® Touch Laser
Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression in Treatment-Naïve Adults in Four-Year Data Presented at CROI
Pharmaceutical Investing Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir
U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
